| 注册
首页|期刊导航|河北医学|洛铂联合艾迪注射液治疗NSCLC恶性胸腔积液患者的疗效

洛铂联合艾迪注射液治疗NSCLC恶性胸腔积液患者的疗效

朱娅丽 纪红 王欣

河北医学2017,Vol.23Issue(4):532-535,4.
河北医学2017,Vol.23Issue(4):532-535,4.DOI:10.3969/j.issn.1006-6233.2017.04.002

洛铂联合艾迪注射液治疗NSCLC恶性胸腔积液患者的疗效

Efficacy of Los Platinum Combined Eddy Injection for Patients with Malignant Pleural Effusion

朱娅丽 1纪红 1王欣1

作者信息

  • 1. 航天中心医院,北京100049
  • 折叠

摘要

Abstract

Objective:To observe the effect of eddy injection combined los platinum pleural perfusion on advanced NSCLC patients with malignant pleural effusion and the influence on serum levels of VEGF.Methods: 74 cases of patients with malignant pleural effusion with NSCLC admitted in our hospital from April 2013 to June 2015 were divided into control group and observation group according to random parallel grouping, 37 cases in each group.The patients in the control group were treated with intrapleural perfusion of luo platinum.The patients in the observation group were treated with eddly injection on the basis of the control group.The efficacy after treatment of all the patients and its influence on serum levels of VEGF were compared.Results: After treatment, the clinical remission rate of the control group (67.5%) was significantly higher than that of the control group (48.6%) (P < 0.05).The VECR level of two groups patients(140.22±19.30ng/L vs105.54±13.48ng/L)after treatment were significantly lower than that before treatment (P < 0.05);the degree of decline in observation group was obviously higher than that of control group (P < 0.05);the incidence of patients in observation group with chest pain, bone marrow suppression was lower than that in control group (P < 0.05).Conclusion: The clinical application of los platinum pleural perfusion combined with eddy injection treatment of advanced NSCLC with malignant pleural effusion curative effect significantly, can significantly improve the serum VEGF levels, and high safety and it can be popularized in clinical application.

关键词

洛铂胸腔灌注/艾迪注射液/非小细胞肺癌/恶性胸腔积液/内皮生长因子

Key words

Los platinum pleural perfusion/Eddy injection/Non-small cell lung cancer/Malignant pleural effusion/Endothelial growth factor

引用本文复制引用

朱娅丽,纪红,王欣..洛铂联合艾迪注射液治疗NSCLC恶性胸腔积液患者的疗效[J].河北医学,2017,23(4):532-535,4.

基金项目

国家自然科学基金项目,(编号:30901795) (编号:30901795)

河北医学

OACSTPCD

1006-6233

访问量0
|
下载量0
段落导航相关论文